Outrage over high drug costs unlikely to bring change any time soon
September 23, 2015 at 13:06 PM EDT
The debate about drug-price inflation may lead to fund flight out of biotech-focused mutual funds and ETFS.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.